SMAD3 and urinary bladder carcinoma: In a 2017 study with bladder cancer cells performed by Li et al., a transfection of two separate bladder cancer cell lines with an miR-323a-3p mimic resulted in a suppression of SMAD3, ultimately showing miR-323a-3p-mediated repression of tumor progression [36].